• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Danielle Kirsh

Medtronic to acquire Companion Medical, expands diabetes business

August 11, 2020 By Danielle Kirsh

Medtronic logo updated

Medtronic (NYSE:MDT) today said it would acquire insulin pen manufacturer Companion Medical for an undisclosed amount. Companion Medical’s product portfolio includes the InPen FDA-cleared smart insulin pen system that is paired with an integrated diabetes management app on the market. It is designed to help calculate insulin doses, track active insulin and send reports to caregivers […]

Filed Under: Diabetes, Featured Tagged With: Companion Medical, Medtronic

How COVID-19 impacts FDA interactions with medical device manufacturers

July 2, 2020 By Danielle Kirsh

Emergo-UL-logo

By Stewart Eisenhart, Emergo Group The US Food and Drug Administration may revise performance goals and timelines set under the Medical Device User Fee Amendments IV (MDUFA IV) as emergency efforts targeting the coronavirus pandemic take up more of the agency’s time. Get the full story here at the Emergo Group’s blog. The opinions expressed […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Xeris Pharmaceuticals launches autoinjector for severe hypoglycemia

July 1, 2020 By Danielle Kirsh

gvoke-xeris

Xeris Pharmaceuticals today said it has launched its Gvoke HypoPen glucagon injection to treat severe hypoglycemia. The autoinjector is designed to treat severe hypoglycemia in adults and children with diabetes that are ages two years and older. The premixed autoinjector has no visible needle and has a reliable delivery method. According to the company, 99% […]

Filed Under: Auto-injectors, Diabetes Tagged With: xerispharmaceuticals

Inivata launches lung cancer liquid biopsy test

June 29, 2020 By Danielle Kirsh

inivata-logo

Inivata today announced it has launched its InVisionFirst Lung liquid biopsy in the U.S. through a commercial partnership with NeoGenomics. The device is a ctDNA next-generation sequencing liquid biopsy assay testing 37 genes that are relevant to the care of advanced non-small-cell lung cancer. The results are delivered within seven days and the test is […]

Filed Under: Diagnostics, Oncology Tagged With: Inivata

This wearable patch could treat skin cancers

June 24, 2020 By Danielle Kirsh

purdue-skin-cancer-patch

Researchers at Purdue University have developed a wearable patch that could bring an improved treatment experience to people with melanoma. Conventional melanoma therapies leave patients suffering from the toxicity and side effects of repeated treatments because of aggressive and the recurrent nature of melanoma cells, according to the researchers. The Purdue University wearable patch features […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: Purdue University

China issues new procedures for medical device registration

June 18, 2020 By Danielle Kirsh

Emergo-UL-logo

By Timothy Herr, Emergo Group China’s Center for Medical Device Evaluation (CMDE) issued two announcements recently outlining revised procedures relating to medical device registration. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

How EU MDR and human factors affect design user-friendly software user interfaces

June 16, 2020 By Danielle Kirsh

Emergo-UL-logo

By Kimmy Ansems and Linda Giesselink, Emergo Group Emergo by UL’s Human Factors Research and Design team has extensive experience developing software user interfaces and instructional materials for various medical devices. In the fourth blog post in our series on the European Medical Devices Regulation (MDR) and human factors engineering, we reference various MDR General […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

MDR delay impact extends beyond European Union

June 10, 2020 By Danielle Kirsh

Emergo-UL-logo

By Timothy Herr, Emergo Group While we have reported on the one-year delay of Europe’s Medical Devices Regulation (MDR) due to the COVID-19 pandemic, we have not yet touched on the ramifications that this decision has on countries outside the European Union. The United Kingdom and the nations of the European Free Trade Association (EFTA) […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Insulet resumes next-gen Omnipod pivotal study following software issues

June 5, 2020 By Danielle Kirsh

Insulet

Insulet (NSDQ:PODD) today said it has resumed its pivotal study of its next-generation Omnipod Insulin Management System after pausing the study in March due to a software anomaly. The company paused the study about halfway through completion to correct an issue that could result in the system using an incorrect glucose value that had the potential to impact […]

Filed Under: Diabetes Tagged With: Insulet

IMDRF recommends UL 2900 compliance for medical device cybersecurity

May 21, 2020 By Danielle Kirsh

Emergo-UL-logo

By Stewart Eisenhart, Emergo Group Recent guidance published by the International Medical Devices Regulators Forum (IMDRF) that covers medical device cybersecurity best practices includes recommendations that manufacturers comply with the UL 2900 set of standards for network-connectable devices. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 54
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS